Jonathan I. Lieber - Jan 20, 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Jan 20, 2022
Transactions value $
$0
Form type
4
Date filed
1/21/2022, 03:10 PM
Previous filing
Sep 21, 2021
Next filing
Jun 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.